Lowering Postprandial Glycemia in Children with Type 1 Diabetes After Italian Pizza “Margherita” (TyBoDi2 Study)
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Continuous subcutaneous insulin infusion is considered a safe and effective way to administer insulin in pediatric patients with type 1 diabetes, but achieving satisfactory and stable glycemic control is difficult. Several factors contribute to control, including fine-tuning the basal infusion rate and bolus type and timing. We evaluated the most effective type and timing of a pump-delivered, preprandial bolus in children with type 1 diabetes for a pizza "margherita" meal. SUBJECTS AND METHODS: We assessed the response of 38 children with type 1 diabetes to a meal based on pizza "margherita" (with mozzarella cheese and tomato sauce) after different types and timings of a bolus dose. RESULTS: The glucose levels for 6 h after the meal were lower (i.e., closer to the therapeutic target of <140 mg/dL) when the bolus doses were administered as a simple bolus 15 min before the meal (area under the curve [AUC] 0-6 h, 6.9 ± 14.9 mg/dL/min) versus a simple bolus administered immediately before the meal (AUC 0-6 h, 4.2 ± 25.9 mg/dL/min) (P = not significant) versus a double-wave bolus 30/70 extended over a 6-h period administered 15 min before the meal (AUC 0-6 h, 1.9 ± 21.3 mg/dL/min) (P = not significant) versus a double-wave bolus 30/70 extended over a 6-h period administered immediately before the meal (AUC 0-6 h, 13.3 ± 15.6 mg/dL/min) (P = 0.01). CONCLUSIONS: In the case of a pizza "margherita," our data support the injection of the simple bolus 15 min before a meal, rather than immediately before or delivered as a double-wave bolus, to control the glycemic rise usually observed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association, A. D. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.775 · Cited by 464
Glucose Variability; Does It Matter?
Siegelaar, S. E., Holleman, F., Hoekstra, J. B. L., & DeVries, J. H. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0021 · Cited by 409
Chase, H. P., Saib, S. Z., MacKenzie, T., Hansen, M. M., & Garg, S. K. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00685.x · Cited by 116 · cited 2×
“…tomato sauce, and some mozzarella cheese, a very different type of pizza compared with the ones used in the study by Jones et al., 6 Chase et al., 4 and Lee et al., 5 where the lower percentage of CHO and higher percentage of lipids make a dual-wave bolus type preferable, even if not the same in…”
Cited by
Bell, K. J., Smart, C. E., Steil, G. M., Brand-Miller, J. C., King, B., & Wolpert, H. A. (2015) · Diabetes Care · doi:10.2337/dc15-0100 · Cited by 390
Bell, K. J., Toschi, E., Steil, G. M., & Wolpert, H. A. (2016) · Diabetes Care · doi:10.2337/dc15-2855 · Cited by 121
Lopez, P. E., Smart, C. E., McElduff, P., Foskett, D. C., Price, D. A., Paterson, M. A., & King, B. R. (2017) · Diabetic Medicine · doi:10.1111/dme.13392 · Cited by 33
Metwally, M., Cheung, T. O., Smith, R., & Bell, K. J. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108516 · Cited by 29
Al Balwi, R., Al Madani, W., & Al Ghamdi, A. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13436 · Cited by 19
“De Palma et al.23 and Bell et al.20 tested the 30%:70% over 2 h postprandially.”
BackgroundInfluential
Metadata
- Authors
- De Palma, A., Giani, E., Iafusco, D., Bosetti, A., Macedoni, M., Gazzarri, A., Spiri, D., Scaramuzza, A. E., & Zuccotti, G. V.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2011-04
- Volume
- 13
- Issue
- 4
- Pages
- 483-487
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2052768532
- Cited by
- 27
- References
- 3
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.